JP2022091846A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022091846A5 JP2022091846A5 JP2022044473A JP2022044473A JP2022091846A5 JP 2022091846 A5 JP2022091846 A5 JP 2022091846A5 JP 2022044473 A JP2022044473 A JP 2022044473A JP 2022044473 A JP2022044473 A JP 2022044473A JP 2022091846 A5 JP2022091846 A5 JP 2022091846A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- aki
- assay
- fluid sample
- motif chemokine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 claims 17
- 208000009304 Acute Kidney Injury Diseases 0.000 claims 10
- 208000033626 Renal failure acute Diseases 0.000 claims 10
- 201000011040 acute kidney failure Diseases 0.000 claims 10
- 238000003556 assay Methods 0.000 claims 10
- 102000019034 Chemokines Human genes 0.000 claims 8
- 108010012236 Chemokines Proteins 0.000 claims 8
- 210000001124 body fluid Anatomy 0.000 claims 6
- 239000010839 body fluid Substances 0.000 claims 6
- 239000003153 chemical reaction reagent Substances 0.000 claims 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims 4
- 230000002085 persistent effect Effects 0.000 claims 4
- 210000002966 serum Anatomy 0.000 claims 3
- 230000002459 sustained effect Effects 0.000 claims 3
- 230000001154 acute effect Effects 0.000 claims 2
- 229940109239 creatinine Drugs 0.000 claims 2
- 230000007717 exclusion Effects 0.000 claims 2
- 239000012530 fluid Substances 0.000 claims 2
- 208000017169 kidney disease Diseases 0.000 claims 2
- 210000002700 urine Anatomy 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 230000003247 decreasing effect Effects 0.000 claims 1
- 238000003018 immunoassay Methods 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 230000002485 urinary effect Effects 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762445692P | 2017-01-12 | 2017-01-12 | |
| US62/445,692 | 2017-01-12 | ||
| JP2019537845A JP2020504157A (ja) | 2017-01-12 | 2018-01-12 | Ｃ−ｃモチーフケモカインリガンド１４の測定に基づく腎損傷および腎不全の評価および処置のための方法および組成物 |
| PCT/US2018/013561 WO2018132702A1 (en) | 2017-01-12 | 2018-01-12 | Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019537845A Division JP2020504157A (ja) | 2017-01-12 | 2018-01-12 | Ｃ−ｃモチーフケモカインリガンド１４の測定に基づく腎損傷および腎不全の評価および処置のための方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022091846A JP2022091846A (ja) | 2022-06-21 |
| JP2022091846A5 true JP2022091846A5 (enExample) | 2022-06-28 |
Family
ID=62840533
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019537845A Pending JP2020504157A (ja) | 2017-01-12 | 2018-01-12 | Ｃ−ｃモチーフケモカインリガンド１４の測定に基づく腎損傷および腎不全の評価および処置のための方法および組成物 |
| JP2022044473A Pending JP2022091846A (ja) | 2017-01-12 | 2022-03-18 | Ｃ－ｃモチーフケモカインリガンド１４の測定に基づく腎損傷および腎不全の評価および処置のための方法および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019537845A Pending JP2020504157A (ja) | 2017-01-12 | 2018-01-12 | Ｃ−ｃモチーフケモカインリガンド１４の測定に基づく腎損傷および腎不全の評価および処置のための方法および組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US11353465B2 (enExample) |
| EP (2) | EP4063853A1 (enExample) |
| JP (2) | JP2020504157A (enExample) |
| CN (2) | CN114088950A (enExample) |
| AU (1) | AU2018207151B2 (enExample) |
| CA (1) | CA3049444A1 (enExample) |
| MX (1) | MX2019008260A (enExample) |
| WO (1) | WO2018132702A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4063853A1 (en) * | 2017-01-12 | 2022-09-28 | Astute Medical, Inc. | Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement |
| CN112041341B (zh) | 2017-12-28 | 2024-05-24 | 机敏医药股份有限公司 | Ccl14的抗体和检测 |
| WO2020243011A1 (en) * | 2019-05-24 | 2020-12-03 | Astute Medical, Inc. | Methods for evaluation and treatment of renal injury based on c-c motif chemokine ligand 14 measurement |
| US20220356238A1 (en) * | 2019-07-02 | 2022-11-10 | Astute Medical, Inc. | Antibodies and assays for ccl14 |
| US20240027473A1 (en) * | 2020-11-18 | 2024-01-25 | Astute Medical, Inc. | Methods and compositions for treatment of renal injury and renal failure |
| CN113555122B (zh) * | 2021-07-21 | 2024-04-26 | 中南大学湘雅二医院 | 一种重症脓毒症患者一过性和持续性aki的预测模型及其构建方法 |
| US20250298037A1 (en) * | 2022-03-03 | 2025-09-25 | Astute Medical, Inc. | Methods and compositions for assessing and treating persistent acute kidney injury based on c-c motif chemokine ligand 14 measurement |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
| US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
| US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
| WO1992005282A1 (en) | 1990-09-14 | 1992-04-02 | Biosite Diagnostics, Inc. | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
| US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
| FI934437L (fi) | 1991-04-10 | 1993-11-22 | Biosite Diagnostics Inc | Crosstalk-inhibitorer och deras anvaendning |
| CA2107899A1 (en) | 1991-04-10 | 1992-10-11 | Gunars Edwin Valkirs | Novel conjugates and assays for simultaneous detection of multiple ligands |
| US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
| US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
| US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
| US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
| US6811773B1 (en) * | 1993-12-22 | 2004-11-02 | Human Genome Sciences, Inc. | Human monocyte colony inhibitory factor (M-CIF) polypeptides |
| US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
| US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
| US6057098A (en) | 1997-04-04 | 2000-05-02 | Biosite Diagnostics, Inc. | Polyvalent display libraries |
| CN1646695A (zh) | 2002-02-12 | 2005-07-27 | 夸克生物技术公司 | Axl受体在诊断和治疗肾病中的应用 |
| CA2614935A1 (en) * | 2005-07-21 | 2007-02-01 | The Johns Hopkins University | Methods of detecting and treating acute kidney injury |
| CN103399155A (zh) * | 2007-03-26 | 2013-11-20 | 诺瓦提斯公司 | 用于监测肾功能的预测性的肾安全性生物标志物和生物标志物标签 |
| WO2009038742A2 (en) * | 2007-09-20 | 2009-03-26 | Caritas St. Elizabeth's Medical Center Of Boston, Inc. | Method for estimating risk of acute kidney injury |
| JP5947544B2 (ja) * | 2008-08-29 | 2016-07-06 | アスチュート メディカル，インコーポレイテッド | 腎損傷および腎不全の診断および予後のための方法および組成物 |
| AU2009308375B2 (en) | 2008-10-21 | 2015-06-25 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| CA2770189A1 (en) | 2009-08-07 | 2011-02-10 | Rules-Based Medicine, Inc. | Methods and devices for detecting kidney transplant rejection |
| NZ600160A (en) | 2009-11-07 | 2014-05-30 | Astute Medical Inc | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| ES2818138T3 (es) * | 2009-12-20 | 2021-04-09 | Astute Medical Inc | Métodos y composiciones para el diagnóstico y pronóstico de lesión renal e insuficiencia renal |
| US20120156701A1 (en) | 2009-12-20 | 2012-06-21 | Joseph Anderberg | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP2666872B1 (en) | 2010-02-05 | 2016-04-27 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP2585827A4 (en) | 2010-06-23 | 2013-12-04 | Astute Medical Inc | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND FORECASTING kidney injury and kidney insufficiency |
| EP2585825B1 (en) | 2010-06-23 | 2018-01-10 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| US20130165344A1 (en) * | 2010-06-23 | 2013-06-27 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP2694974B1 (en) | 2011-04-04 | 2015-10-21 | Universiteit Gent | Biomarkers for acute kidney injury |
| AU2012312907A1 (en) | 2011-08-26 | 2014-03-13 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP3540440B1 (en) | 2011-12-08 | 2022-09-28 | Astute Medical, Inc. | Methods and uses for evaluating renal injury and renal status |
| WO2013096740A1 (en) | 2011-12-21 | 2013-06-27 | Alere San Diego Inc. | Methods and compositions for assigning likelihood of chronic kidney disease progression |
| EP3968022A1 (en) * | 2014-10-20 | 2022-03-16 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
| EP4063853A1 (en) * | 2017-01-12 | 2022-09-28 | Astute Medical, Inc. | Methods and compositions for evaluation and treatment of renal injury and renal failure based on c-c motif chemokine ligand 14 measurement |
-
2018
- 2018-01-12 EP EP22155208.6A patent/EP4063853A1/en not_active Withdrawn
- 2018-01-12 AU AU2018207151A patent/AU2018207151B2/en active Active
- 2018-01-12 JP JP2019537845A patent/JP2020504157A/ja active Pending
- 2018-01-12 MX MX2019008260A patent/MX2019008260A/es unknown
- 2018-01-12 CN CN202111365747.3A patent/CN114088950A/zh active Pending
- 2018-01-12 WO PCT/US2018/013561 patent/WO2018132702A1/en not_active Ceased
- 2018-01-12 EP EP18738815.2A patent/EP3568695A4/en not_active Withdrawn
- 2018-01-12 US US16/475,326 patent/US11353465B2/en active Active
- 2018-01-12 CA CA3049444A patent/CA3049444A1/en active Pending
- 2018-01-12 CN CN201880012782.7A patent/CN110651187A/zh active Pending
-
2022
- 2022-03-18 JP JP2022044473A patent/JP2022091846A/ja active Pending
- 2022-05-06 US US17/739,009 patent/US12203944B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022091846A5 (enExample) | ||
| Lee et al. | Diagnostic and prognostic value of presepsin and procalcitonin in non-infectious organ failure, sepsis, and septic shock: a prospective observational study according to the Sepsis-3 definitions | |
| JP2022046669A5 (enExample) | ||
| Schley et al. | Comparison of plasma and urine biomarker performance in acute kidney injury | |
| Bastarache et al. | Validation of a multiplex electrochemiluminescent immunoassay platform in human and mouse samples | |
| JP2019535015A5 (enExample) | ||
| US20110189698A1 (en) | Protein Biomarkers and Methods for Diagnosing Kawasaki Disease | |
| Rodrigues et al. | Definitions, phenotypes, and subphenotypes in acute kidney injury—Moving towards precision medicine | |
| JP2019530875A5 (enExample) | ||
| CN102507918B (zh) | 抗环瓜氨酸肽抗体测定试剂盒 | |
| CN102253217A (zh) | 一种胶乳颗粒增强型中性粒细胞明胶酶相关脂质运载蛋白检测试剂盒 | |
| JP2020504157A5 (enExample) | ||
| JP2014505259A (ja) | 慢性心不全における予後診断および診断の方法 | |
| CN104849473A (zh) | 一种尿微量白蛋白检测试剂盒及其制备 | |
| JP2019053067A (ja) | 急性腎臓損傷 | |
| JP2013521490A (ja) | 腎臓予後予測アッセイ | |
| US20220317131A1 (en) | Assay to detect and quantitate specific antibodies for various redox forms of hmgb1 | |
| KR20220066149A (ko) | 패혈증 관리 | |
| WO2015192854A2 (en) | Methods and tools for predicting steatohepatitis | |
| CN102906569A (zh) | Flc作为生物标记 | |
| Archdekin et al. | Non‐invasive differentiation of non‐rejection kidney injury from acute rejection in pediatric renal transplant recipients | |
| Hassan et al. | Pleural fluid analysis: standstill or a work in progress? | |
| Natarajan et al. | Aptamer based lateral flow assays for rapid and sensitive detection of CKD marker cystatin C | |
| KR101788404B1 (ko) | 활동성 루푸스신염 검출용 바이오마커 및 그 용도 | |
| WO2023122562A3 (en) | Reflex test for immunoassay for anti-sars-cov-2 antibodies |